|

Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma

RECRUITINGSponsored by Zealand University Hospital
Actively Recruiting
SponsorZealand University Hospital
Started2019-02-01
Est. completion2025-12-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03414827

Summary

Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients who have been diagnosed with kidney cancer.

Exclusion Criteria:

* Patients without signs of malignancy at final histology report.
* Incapacitated patients.

Conditions2

CancerKidney Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.